col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


27 Ergebisse       Seite 1

 [1] 
Wiley: Journal of Extracellular Vesicles
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2026―Mai―28 DAMP Laden Extracellular Vesicles From the Airways of Patients With Severe SARS-CoV-2 Respiratory Infection Compromise Inflammation and Cellular Metabolism April Rees, Oliver Richards, Molly E Raikes, Megan Chambers, Sophie G Reed, Ceri Battle, et al. (+9)
2 [GO] 2026―Apr―30 When Viruses Talk through Extracellular Vesicles: a New Perspective on Sars-Cov-2-Induced Neurodegeneration Gunjan Bawne, Loet Coenen, Erik Nutma, Jinte Middeldorp, Magdalena J. Lorenowicz
3 [GO] 2026―Mrz―13 Reduced Mortality in COVID-19 Patients Treated With Inhaled Extracellular Vesicles Expressing CD24 Shiran Shapira, Guy Vishnevsky, Hadas Yaakobi, Gil Shenberg, Mays Motlaq, Eliezer Liberman, et al. (+6)
4 [GO] 2025―Apr―10 Extracellular Vesicles Alter Trophoblast Function in Pregnancies Complicated by COVID-19 Thea N. Golden, Sneha Mani, Rebecca L. Linn, Rita Leite, Natalie A. Trigg, Annette Wilson, et al. (+7)
5 [GO] 2024―Nov―19 Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19 Diego de Miguel-Perez, Marisol Arroyo-Hernandez, Sabrina La Salvia, Muthukumar Gunasekaran, Edward M. Pickering, Stephanie Avila, et al. (+17)
6 [GO] 2024―Sep―10 Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in SARS-CoV-2 and H1N1 influenza-induced acute lung injury Jun Ho Lee, Hyungtaek Jeon, Jan Lötvall, Byong Seung Cho
7 [GO] 2024―Jul―25 Human placental mesenchymal stromal cell-derived small extracellular vesicles as a treatment for severe COVID-19: A double-blind randomized controlled clinical trial Mohammad Hossein Zamanian, Amir Hossein Norooznezhad, Zohreh Hosseinkhani, Daryoush Hassaninia, Feizollah Mansouri, Siavash Vaziri, et al. (+9)
8 [GO] 2024―Jul―15 CD66b+/CD68+ circulating extracellular vesicles, lactate dehydrogenase and neutrophil-to-lymphocyte ratio can differentiate coronavirus disease 2019 severity during and after infection Rosa Suades, Maria Francesca Greco, Paula Prieto, Teresa Padró, Yvan Devaux, Pere Domingo, Lina Badimon
9 [GO] 2024―Feb―10 Bioengineered small extracellular vesicles deliver multiple SARS-CoV-2 antigenic fragments and drive a broad immunological response Hannah K. Jackson, Heather M. Long, Juan Carlos Yam-Puc, Roberta Palmulli, Tracey A. Haigh, Pehuén Pereyra Gerber, et al. (+8)
10 [GO] 2022―Dez―21 The importance of activated TMPRSS2 in the proviral role of small extracellular vesicles in SARS-CoV-2 infection Sze Keong Tey, Judy Wai Ping Yam
11 [GO] 2022―Dez―05 Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS-CoV-2 infected human lung epithelial cells Supasek Kongsomros, Nutkridta Pongsakul, Jirawan Panachan, Ladawan Khowawisetsut, Jinjuta Somkird, Chak Sangma, et al. (+9)
12 [GO] 2022―Dez―01 Meet changes with constancy: Defence, antagonism, recovery, and immunity roles of extracellular vesicles in confronting SARS-CoV-2 Xiaohang Chen, Huifei Li, Haoyue Song, Jie Wang, Xiaoxuan Zhang, Pengcheng Han, Xing Wang
13 [GO] 2022―Okt―22 Proviral role of human respiratory epithelial cell-derived small extracellular vesicles in SARS-CoV-2 infection François Berry, Margot Morin-Dewaele, Amene Majidipur, Thibaud Jamet, Sophie Bartier, Eva Ignjatovic, et al. (+21)
14 [GO] 2022―Aug―18 Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients Tobias Tertel, Sergej Tomić, Jelena Đokić, Dušan Radojević, Dejan Stevanović, Nataša Ilić, et al. (+2)
15 [GO] 2022―Mai―18 ACE2-enriched extracellular vesicles enhance infectivity of live SARS-CoV-2 virus Sze Keong Tey, Hoiyan Lam, Samuel Wan Ki Wong, Hanjun Zhao, Kelvin Kai-Wang To, Judy Wai Ping Yam
16 [GO] 2022―Mai―09 Erratum: A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants
17 [GO] 2022―Mrz―15 A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants Linglei Jiang, Tom A.P. Driedonks, Wouter S.P. Jong, Santosh Dhakal, H. Bart van den Berg van Saparoea, Ioannis Sitaras, et al. (+19)
18 [GO] 2022―Jan―04 Engineered small extracellular vesicles displaying ACE2 variants on the surface protect against SARS-CoV-2 infection Hark Kyun Kim, Junhyung Cho, Eunae Kim, Junsik Kim, Jeong-Sun Yang, Kyung-Chang Kim, et al. (+14)
19 [GO] 2021―Dez―07 Millisecond dynamic of SARS-CoV-2 spike and its interaction with ACE2 receptor and small extracellular vesicles Keesiang Lim, Goro Nishide, Takeshi Yoshida, Takahiro Watanabe-Nakayama, Akiko Kobayashi, Masaharu Hazawa, et al. (+3)
20 [GO] 2021―Dez―02 Binding of phosphatidylserine-positive microparticles by PBMCs classifies disease severity in COVID-19 patients Lisa Rausch, Konstantin Lutz, Martina Schifferer, Elena Winheim, Rudi Gruber, Elina F. Oesterhaus, et al. (+11)
21 [GO] 2021―Jul―04 Extracellular vesicle-mediated endothelial apoptosis and EV-associated proteins correlate with COVID-19 disease severity Balaji Krishnamachary, Christine Cook, Ashok Kumar, Leslie Spikes, Prabhakar Chalise, Navneet K. Dhillon
22 [GO] 2021―Jun―19 Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies Zach Troyer, Najwa Alhusaini, Caroline O. Tabler, Thomas Sweet, Karina Inacio Ladislau Carvalho, Daniela M. Schlatzer, et al. (+4)
23 [GO] 2021―Jun―04 Early prediction of COVID-19 severity using extracellular vesicle COPB2 Yu Fujita, Tokio Hoshina, Juntaro Matsuzaki, Yusuke Yoshioka, Tsukasa Kadota, Yusuke Hosaka, et al. (+15)
24 [GO] 2020―Dez―29 Extracellular vesicles containing ACE2 efficiently prevent infection by SARS-CoV-2 Spike protein-containing virus Federico Cocozza, Nathalie Névo, Ester Piovesana, Xavier Lahaye, Julian Buchrieser, Olivier Schwartz, et al. (+4)
25 [GO] 2020―Dez―03 COVID-19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies? Philip W. Askenase
26 [GO] 2020―Aug―24 Salivary extracellular vesicles inhibit Zika virus but not SARS-CoV-2 infection Carina Conzelmann, Rüdiger Groß, Min Zou, Franziska Krüger, André Görgens, Manuela O Gustafsson, et al. (+3)
27 [GO] 2020―Aug―06 Systematic review of extracellular vesicle-based treatments for lung injury: are EVs a potential therapy for COVID-19? Kasra Khalaj, Rebeca Lopes Figueira, Lina Antounians, Giuseppe Lauriti, Augusto Zani
 [1] 

27 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.004 sec